144 related articles for article (PubMed ID: 18467681)
1. A review of islet of Langerhans degeneration in rodent models of type 2 diabetes.
Nugent DA; Smith DM; Jones HB
Toxicol Pathol; 2008 Jun; 36(4):529-51. PubMed ID: 18467681
[TBL] [Abstract][Full Text] [Related]
2. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
Hayden MR; Tyagi SC
JOP; 2002 Jul; 3(4):86-108. PubMed ID: 12110767
[TBL] [Abstract][Full Text] [Related]
3. Islet protein profiling.
Bergsten P
Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():97-117. PubMed ID: 19817793
[TBL] [Abstract][Full Text] [Related]
4. Glucose-induced insulin mRNA accumulation is impaired in islets from neonatal streptozotocin-treated rats.
Briaud I; Rouault C; Bailbé D; Portha B; Reach G; Poitout V
Horm Metab Res; 2000 Feb; 32(2):53-6. PubMed ID: 10741685
[TBL] [Abstract][Full Text] [Related]
5. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
[TBL] [Abstract][Full Text] [Related]
6. Morphometrical and biochemical differences of endocrine pancreata between spontaneously hypertensive and normotensive rats with or without neonatal streptozotocin-induced diabetes.
Iwase M; Nunoi K; Kikuchi M; Maki Y; Kodama T; Sadoshima S; Fujishima M
Lab Invest; 1989 Jan; 60(1):102-5. PubMed ID: 2521365
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic islet-specific overexpression of Reg3β protein induced the expression of pro-islet genes and protected the mice against streptozotocin-induced diabetes mellitus.
Xiong X; Wang X; Li B; Chowdhury S; Lu Y; Srikant CB; Ning G; Liu JL
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E669-80. PubMed ID: 21245462
[TBL] [Abstract][Full Text] [Related]
8. Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus.
Hayden MR
JOP; 2002 Sep; 3(5):126-38. PubMed ID: 12221327
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative histochemical studies of islands of Langerhans in the (Psammomys obesus) in the development of diabetes mellitus. II. Surface measurement of the islands].
Hahn von Dorsche H; Stiller KJ; Scheven C; Timm D
Gegenbaurs Morphol Jahrb; 1984; 130(5):671-5. PubMed ID: 6392004
[TBL] [Abstract][Full Text] [Related]
10. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
11. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
12. Distinctions between islet neogenesis and β-cell replication: implications for reversal of Type 1 and 2 diabetes.
Levetan C
J Diabetes; 2010 Jun; 2(2):76-84. PubMed ID: 20923488
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
Matveyenko AV; Butler PC
Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
[TBL] [Abstract][Full Text] [Related]
14. Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus.
Movassat J; Saulnier C; Portha B
Diabete Metab; 1995 Dec; 21(5):365-70. PubMed ID: 8586154
[TBL] [Abstract][Full Text] [Related]
15. A fibrin gel carrier system for islet transplantation into kidney subcapsule.
Lim JY; Min BH; Kim BG; Han HJ; Kim SJ; Kim CW; Han SS; Shin JS
Acta Diabetol; 2009 Sep; 46(3):243-8. PubMed ID: 19030773
[TBL] [Abstract][Full Text] [Related]
16. Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis.
Brissova M; Blaha M; Spear C; Nicholson W; Radhika A; Shiota M; Charron MJ; Wright CV; Powers AC
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E707-14. PubMed ID: 15562255
[TBL] [Abstract][Full Text] [Related]
17. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
18. [Morphological changes of islet of Langerhans in an animal model of type 2 diabetes].
Seiça RM; Martins MJ; Pessa PB; Santos RM; Rosário LM; Suzuki KI; Martins MI
Acta Med Port; 2003; 16(6):381-8. PubMed ID: 15631848
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
Kahn SE; Hull RL; Utzschneider KM
Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
[TBL] [Abstract][Full Text] [Related]
20. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
